Ovarian ultrasound and ovarian and adrenal hormones before and after treatment for hyperthyroidism

Gynecologic and Obstetric Investigation

Volumn 54, Issue 1, 2002, Pages 50-55

  Skjöldebrand Sparre, Lottie ^a   Kollind, Magnus ^a   Carlström, Kjell ^b  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Corticosteroids; Hyperthyroidism; Ovarian ultrasonography; Sex steroids

Indexed keywords

HYDROCORTISONE; PRASTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; THIAMAZOLE; THYROXINE; TRANSCORTIN;

ADRENAL GLAND; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE DURATION; FEMALE; FREE THYROXINE INDEX; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTHYROIDISM; OVARY; PRIORITY JOURNAL; STEROID BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; THYROID HORMONE BLOOD LEVEL; TREATMENT OUTCOME; ULTRASOUND;

ADRENAL CORTEX HORMONES; ADULT; ANTITHYROID AGENTS; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; HYDROCORTISONE; HYPERTHYROIDISM; METHIMAZOLE; MIDDLE AGED; OVARY; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; THYROXINE; TRANSCORTIN;

EID: 0036391765     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065573     Document Type: Article

References (25)

1. Koutras DA: Disturbances of menstruation in thyroid disease. Ann NY Acad Sci 1997;816:280-284.
2. Thomas R, Reid RL: Thyroid disease and reproductive dysfunction: A review. Obstet Gynecol 1987;70:789-798.
3. Krassas GE, Ponikides N, Kaltsas Th, Papadopoulo P, Batgrinos M: Menstrual disturbances in thyreotoxicosis. Clin Endocrinol 1994;40:641-644.
4. Adashi EY: The ovarian follicular apparatus; in Adashi EA, Rock JA, Rosenwaks Z (eds): Reproductive Endocrinology, Surgery and Technology. Philadelphia, Lippincott-Raven, 1996.
5. Ferin MJ: The menstrual cycle; in Adashi EA, Rock JA, Rosenwaks Z (eds): Reproductive Endocrinology, Surgery and Technology. Philadelphia, Lippincott-Raven, 1996.
6. Bakos O, Lundquist O, Wide L, Bergh T: Ultrasonographical and hormonal description of the normal ovulatory menstrual cycle. Acta Obstet Gynecol Scand 1994;73:790-796.
7. Vigersky RA, Kong S, Sauer M, Lipsett MB, Loriaux DL: Relative binding of testosterone and estradiol to testosterone-estradiol-binding globulin. J Clin Endocrinol Metab 1979;49:899-904.
8. Lindholm C, Lindén Hirschberg A, Carlström K, von Schoultz B: Hormone anabolic/catabolic balance in female endurance athletes. Obstet Gynecol Invest 1993;36:176-180.
9. Aoki N, Maruyama Y, Imamura M, et al: Studies of sex-steroid-binding plasma protein (SBP) in Grave's disease before and during antithyroid drug therapy. Acta Endocrinol (Copenh) 1986;113:249-254.
10. Coolens J-L, Van Baelen H, Heyns W: Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem 1987;26:197-202.
11. Barlow JW, Crowe TC, Cowen NL, Raggatt LE, Topliss DJ, Stockigt JR: Stimulation of sex hormone-binding globulin mRNA and attenuation of corticosteroid-binding globulin mRNA by triiodothyronine in human hepatoma cells. Eur J Endocrinol 1994;130:166-170.
12. Tsatsoulis A, Johnson EO, Kalogera CH, Seferfiadis K, Tsolas O: The effect of thyrotoxicosis on adrenocortical reserve. Eur J Endocrinol 2000;142:231-235.
13. Földes J, Lakatos P, Zsadanyi J, Horvath C: Decreased serum IGF-I and dehydroepian-drosterone sulphate may be risk factors for the development of reduced bone mass in post-menopausal women with endogenous subclinical hyperthyroidism. Eur J Endocrinol 1997;136:277-281.
14. Bakri YN, Bakhashwain M, Hugosson C: Massive theca-lutein cysts, virilization and hypothyroidism associated with normal pregnancy. Acta Obstet Gynecol Scand 1994;73:153-155.
15. Hansen KA, Tho SPT, Hanly M, Moretuzzo RW, McDonough PG: Massive ovarian enlargement in primary hyperthyroidism. Fertil Steril 1997;67:169-171.
16. Loric S, Duron F, Guechot J, Aubert P, Gobodeau J: Testosterone and its binding in hyperthyroid women before and under antithyroid drug therapy. Acta Endocrinol (Copenh) 1989;121:443-446.
17. Ford HC, Cooke RR, Keightley EA, Feek CM: Serum levels of free and bound testosterone in hyperthyroidism. Clin Endocrinol 1992;36:187-192.
18. Luthold WW, Borges MF, Marcondes JAM, Hakohyama M, Wajchenberg BL, Kirschner MA: Serum testosterone fractions in women: Normal and abnormal clinical states. Metabolism 1993;42:638-643.
19. Ueshiba H, Takeda S, Matoba H, et al: Serum androgen levels in hyperthyroid women. Exp Clin Endocrinol Diabetes 1997;105:359-362.
20. Maruo T, Hayashi M, Maruo H, Yamamoto T, Okada H, Mochizuki M: The role of thyroid hormone as a biological amplifier of the actions of follicle-stimulating hormone in the functional differentiation of cultured porcine granulosa cells. Endocrinolology 1987;121:1233-1241.
21. Wakim AN, Polizotto SL, Buffo MJ, Marrero MA, Burholt DR: Thyroid hormones in human follicular fluid and thyroid hormone receptors in human granulosa cells. Fertil Steril 1993;59:1187-1190.
22. Wakim AN, Paljug WR, Jasnosz KM, Alhakim N, Nrown AB, Burholt DR: Thyroid hormone receptor messenger ribonucleic acid in human granulosa and stroma cells. Fertil Steril 1994;62:531-534.
23. Zhang SS, Carrillo AJ, Darling DS: Expression of multiple thyroid hormone receptor mRNAs in human oocytes, cumulus cells and granulosa cells. Mol Hum Reprod 1997;3:552-562.
24. Gustafson O, Carlström K, Nylund L: Does hyperandrogenism explain lower IVF success rates in smokers? Acta Obstet Gynecol Scand 1995;75:149-156.
25. Hillier SG, Tetsuka M: Role of androgens in follicle maturation and atresia. Ballieres Clin Obstet Gynecol 1997;11:248-260.